Company Introduction
Zhejiang Sundoc Pharmaceutical Science and Tech Co., Ltd is located in Hangzhou, China, a city known as "paradise on earth". It is a national high-tech enterprise focusing on the industrialization development of two fields of complex injections, that is long-acting release drug delivery system (LAR DDS) and targeted drug delivery system (TDDS). The company is a key enterprise supported by the local biological and pharmaceutical industry policies, and has established Zhejiang high-tech R&D center for LAR DDS and TDDS. Sundoc was listed in the national equities exchange and quotations system in 2015 as innovation part on the market-making transfer platform.

Sundoc is committed to establishing an international first-class and China’s leading technology platform for complex injection. Based on the two research fields, i.e. LAR DDS and TDDS, the company focuses on four kinds of complex injection technologies, which are PLG microspheres, nanocrystallization, liposomes and lipid microspheres, and is researching more than ten products, the indications of which include four major diseases that seriously endanger human health: malignant tumors, neuropsychiatric diseases, endocrine diseases and cardiovascular diseases.

Sundoc has more than 100 employees. With the security of “Four First-Class”(namely first-class projects, first-class facilities, first-class team, first-class management), Sundoc aims at becoming a global enterprise , an international first-class and China’s leading advanced pharmaceutical research enterprise. Our mission lies in seeking safer and more effective drug products globally to meet Chinese need.